[go: up one dir, main page]

DK1171165T3 - Injektion af autolog knoglemarv i myokardiet - Google Patents

Injektion af autolog knoglemarv i myokardiet

Info

Publication number
DK1171165T3
DK1171165T3 DK00919831T DK00919831T DK1171165T3 DK 1171165 T3 DK1171165 T3 DK 1171165T3 DK 00919831 T DK00919831 T DK 00919831T DK 00919831 T DK00919831 T DK 00919831T DK 1171165 T3 DK1171165 T3 DK 1171165T3
Authority
DK
Denmark
Prior art keywords
bone marrow
autologous bone
myocardium
injection
stimulated
Prior art date
Application number
DK00919831T
Other languages
Danish (da)
English (en)
Inventor
Ran Kornowski
Shmuel Fuchs
Martin B Leon
Stephen E Epstein
Original Assignee
Ran Kornowski
Shmuel Fuchs
Stephen E Epstein
Martin B Leon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ran Kornowski, Shmuel Fuchs, Stephen E Epstein, Martin B Leon filed Critical Ran Kornowski
Application granted granted Critical
Publication of DK1171165T3 publication Critical patent/DK1171165T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00919831T 1999-03-30 2000-03-30 Injektion af autolog knoglemarv i myokardiet DK1171165T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12680099P 1999-03-30 1999-03-30
US13837999P 1999-06-09 1999-06-09
PCT/US2000/008353 WO2000057922A1 (fr) 1999-03-30 2000-03-30 Injection intramyocardique de moelle osseuse autologue

Publications (1)

Publication Number Publication Date
DK1171165T3 true DK1171165T3 (da) 2007-09-03

Family

ID=26825036

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00919831T DK1171165T3 (da) 1999-03-30 2000-03-30 Injektion af autolog knoglemarv i myokardiet

Country Status (9)

Country Link
EP (1) EP1171165B1 (fr)
JP (1) JP2002540176A (fr)
AT (1) ATE363293T1 (fr)
AU (1) AU767402B2 (fr)
CA (1) CA2368677C (fr)
DE (1) DE60035035T2 (fr)
DK (1) DK1171165T3 (fr)
ES (1) ES2284489T3 (fr)
WO (1) WO2000057922A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030129750A1 (en) * 1998-02-05 2003-07-10 Yitzhack Schwartz Homing of donor cells to a target zone in tissue using active therapeutics or substances
US20030125615A1 (en) * 1998-02-05 2003-07-03 Yitzhack Schwartz Homing of autologous cells to a target zone in tissue using active therapeutics or substances
US20030113303A1 (en) * 1998-02-05 2003-06-19 Yitzhack Schwartz Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances
US7097832B1 (en) 1999-03-30 2006-08-29 Myocardial Therapeutics, Inc. Intramyocardial injection of autologous bone marrow
CA2810249A1 (fr) 2000-06-05 2001-12-13 The Trustees Of Columbia University In The City Of New York Identification et utilisation des cellules progenitrices endotheliales derivees de la moelle osseuse, destinees a ameliorer la fonction du myocarde apres un accident ischemique
JP2004516242A (ja) * 2000-07-26 2004-06-03 サイムド ライフ システムズ， インコーポレイテッド 心筋および骨格筋の虚血組織に骨髄由来の細胞移植をすることによる、治療を目的とした血管形成
US20020061587A1 (en) 2000-07-31 2002-05-23 Piero Anversa Methods and compositions for the repair and/or regeneration of damaged myocardium
US7862810B2 (en) 2000-07-31 2011-01-04 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
US7547674B2 (en) 2001-06-06 2009-06-16 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
JP2005501802A (ja) * 2001-01-23 2005-01-20 ボストン　サイエンティフィック　コーポレイション 虚血心筋を処置するための限局性心筋注入方法
US20030199464A1 (en) 2002-04-23 2003-10-23 Silviu Itescu Regeneration of endogenous myocardial tissue by induction of neovascularization
JP4111950B2 (ja) * 2002-05-30 2008-07-02 ミオカーディアル セラピューティクス インコーポレイティッド 自家骨髄の心筋内注射
EP1529525A1 (fr) * 2003-11-06 2005-05-11 Aventis Pharma Deutschland GmbH Stimulateurs de la Transcription de l' eNOS dans le traitement cellulaire des ischemies cardiaques
EP3205349A1 (fr) * 2006-10-02 2017-08-16 Orthocell Limited Procédé de fabrication de composants natifs, tels que des facteurs de croissance ou des protéines de matrice extracellulaire, par mise en culture de cellules d'échantillons de tissu pour la réparation tissulaire
AU2007321928A1 (en) 2006-11-24 2008-05-29 Regents Of The University Of Minnesota Endodermal progenitor cells
US8496926B2 (en) 2007-04-16 2013-07-30 Biocardia, Inc. Treatment for chronic myocardial infarction
AU2008323719B2 (en) 2007-11-09 2013-04-04 New York Medical College Methods for the repair and/or regeneration of damaged myocardium using variants of hepatocyte growth factor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2064558C (fr) * 1989-09-25 2001-01-30 Ian B. Pragnell Methode d'inhibition de la croissance de cellules souches
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
WO1999000486A1 (fr) * 1997-06-26 1999-01-07 Cli Oncology, Inc. Compositions et procedes permettant d'induire la croissance et la differenciation de cellules souches hematopietiques

Also Published As

Publication number Publication date
EP1171165B1 (fr) 2007-05-30
EP1171165A1 (fr) 2002-01-16
ES2284489T3 (es) 2007-11-16
JP2002540176A (ja) 2002-11-26
EP1171165A4 (fr) 2002-07-31
CA2368677A1 (fr) 2000-10-05
AU767402B2 (en) 2003-11-06
CA2368677C (fr) 2012-07-10
AU4045200A (en) 2000-10-16
DE60035035T2 (de) 2008-01-31
WO2000057922A1 (fr) 2000-10-05
ATE363293T1 (de) 2007-06-15
DE60035035D1 (de) 2007-07-12

Similar Documents

Publication Publication Date Title
DK1171165T3 (da) Injektion af autolog knoglemarv i myokardiet
Ondrésik et al. Management of knee osteoarthritis. Current status and future trends
Saito et al. Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction
DE60128451D1 (de) Beschichtung welche ein anhaften von endothelzellen stimuliert
Kim et al. The enhancement of mature vessel formation and cardiac function in infarcted hearts using dual growth factor delivery with self-assembling peptides
RU2005128964A (ru) Способы использования клеток, полученных из жировой ткани, в терапии сердечно-сосудистых состояний
EA199900861A1 (ru) Усеченные белки, родственные фактору роста эндотелия сосудов
Vu et al. An autologous platelet-rich plasma hydrogel compound restores left ventricular structure, function and ameliorates adverse remodeling in a minimally invasive large animal myocardial restoration model: a translational approach: Vu and Pal “Myocardial Repair: PRP, Hydrogel and Supplements”
DE69028694D1 (de) Verfahren und zubereitungen zur krebsbehandlung mit oligonukleotiden
DE60107815D1 (de) Methode zur behandlung von tumoren welche den vaskulären endothelialen wachstumsfaktor d exprimieren
Lancaster et al. An electrically coupled tissue-engineered cardiomyocyte scaffold improves cardiac function in rats with chronic heart failure
Avitall et al. Iontophoretic transmyocardial drug delivery. A novel approach to antiarrhythmic drug therapy.
Liu et al. Liposome‐mediated transfer of vascular endothelial growth factor cDNA augments survival of random‐pattern skin flaps in the rat
Ding et al. Effect of calcium alginate microsphere loaded with vascular endothelial growth factor on adipose tissue transplantation
Yamamoto et al. Improved therapeutic efficacy in cardiomyocyte transplantation for myocardial infarction with release system of basic fibroblast growth factor
Haider et al. MyoCell, a cell-based, autologous skeletal myoblast therapy for the treatment of cardiovascular diseases
Hsueh et al. Novel skin chamber for rat ischemic flap studies in regenerative wound repair
Li et al. Enhanced human adipose‐derived stem cells with VEGFA and bFGF mRNA promote stable vascular regeneration and improve cardiac function following myocardial infarction
Daniel et al. H vessel formation as a marker for enhanced bone healing in irradiated distraction osteogenesis
US20240299149A1 (en) Implantable Devices Coated With Extracellular Matrix
US20140275905A1 (en) Coated Surgical Mesh, and Corresponding Systems and Methods
CN109999185B (zh) 一种用于修复损伤的组合物及其制备方法和用途
ATE228843T1 (de) Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit
McGregor et al. Pentagastrin stimulation of human colon carcinoma
Boye et al. Cardioporation enhances myocardial gene expression in rat heart